Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03864042
Title Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Array BioPharma


skin melanoma

Advanced Solid Tumor


Caffeine + Dextromethorphan + Losartan + Midazolam + Omeprazole


Bupropion + Rosuvastatin

Binimetinib + Encorafenib

Age Groups: senior | adult
Covered Countries USA | ESP | CAN | BEL

Additional content available in CKB BOOST